Literature DB >> 9400429

Efficacy and cost-effectiveness of extracorporeal shock wave lithotripsy for solitary lower pole renal calculi.

D J May1, P S Chandhoke.   

Abstract

PURPOSE: We determined the efficacy of extracorporeal shock wave lithotripsy monotherapy and compared its cost-effectiveness with percutaneous nephrolithotomy for the management of lower pole renal calculi.
MATERIALS AND METHODS: The efficacy (stone-free rates at 3-months posttreatment) of shock wave lithotripsy with the modified Dornier HM3* machine was determined retrospectively in 114 patients with solitary lower pole renal calculi. Using cost data available from patient billing charges and efficacy data from the literature, the cost-effectiveness for percutaneous nephrolithotomy and shock wave lithotripsy as primary therapy was evaluated. To make this cost-effectiveness comparison, we developed a decision analysis model in which a patient in whom primary therapy failed was rendered stone-free with a secondary percutaneous nephrolithotomy procedure.
RESULTS: The stone-free rates of solitary lower pole stones with a size range of less than 10, 11 to 20 and greater than 20 mm. were 76, 74 and 33%, respectively, with a single shock wave lithotripsy treatment. Based on average treatment costs for shock wave lithotripsy and percutaneous nephrolithotomy, the model results show that for stone sizes less than 2 cm. primary lithotripsy therapy followed by nephrolithotomy for failed cases is the least costly approach. For stone sizes greater than 2 cm. primary percutaneous nephrolithotomy may be more cost-effective.
CONCLUSIONS: Whereas shock wave lithotripsy with the Dornier HM3 should be considered the initial treatment choice for most lower pole stones less than 2 cm., primary percutaneous nephrolithotomy should be considered for stones larger than 2 cm.

Entities:  

Mesh:

Year:  1998        PMID: 9400429     DOI: 10.1016/s0022-5347(01)63999-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Retrograde transureteral approach: a safe and efficient treatment for recurrent cystine renal stones.

Authors:  Lorenzo Ruggera; Martina Zanin; Paolo Beltrami; Filiberto Zattoni
Journal:  Urol Res       Date:  2010-12-31

Review 2.  Economic outcomes of treatment for ureteral and renal stones: a systematic literature review.

Authors:  Brian R Matlaga; Jeroen P Jansen; Lisa M Meckley; Thomas W Byrne; James E Lingeman
Journal:  J Urol       Date:  2012-06-13       Impact factor: 7.450

3.  The feasibility of shockwave lithotripsy for treating solitary, lower calyceal stones over 1 cm in size.

Authors:  Tae Beom Kim; Sang Cheol Lee; Khae Hawn Kim; Han Jung; Sang Jin Yoon; Jin Kyu Oh
Journal:  Can Urol Assoc J       Date:  2013 Mar-Apr       Impact factor: 1.862

Review 4.  Economic Considerations in the Management of Nephrolithiasis.

Authors:  Daniel Roberson; Colin Sperling; Ankur Shah; Justin Ziemba
Journal:  Curr Urol Rep       Date:  2020-03-31       Impact factor: 3.092

5.  Outcomes and costs of ureteroscopy, extracorporeal shockwave lithotripsy, and percutaneous nephrolithotomy for the treatment of urolithiasis: an analysis based on health insurance claims data in Germany.

Authors:  Claudia Schulz; Benedikt Becker; Christopher Netsch; Thomas R W Herrmann; Andreas J Gross; Jens Westphal; Thomas Knoll; Hans-Helmut König
Journal:  World J Urol       Date:  2021-12-15       Impact factor: 4.226

6.  Extracorporeal shockwave lithotripsy for lower pole calculi smaller than one centimeter.

Authors:  Christian Chaussy; Thorsten Bergsdorf
Journal:  Indian J Urol       Date:  2008-10

Review 7.  Economics of stone disease/treatment.

Authors:  Walter Ludwig Strohmaier
Journal:  Arab J Urol       Date:  2012-03-22

8.  Management of 1-2 cm renal stones.

Authors:  Aneesh Srivastava; Saurabh S Chipde
Journal:  Indian J Urol       Date:  2013-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.